Sterile Water for Injection, USP

Manufacturer
Nexus Pharmaceuticals Inc
Effective date
2023-07-18
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:25:47

Label at a glance#

ProductSterile Water
Active ingredientWater
Label structure15 sections

Indications and uses

This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

Dosage and administration

The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

Glass Vial

DESCRIPTION

DESCRIPTION SECTION

This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.

Sterile Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection which contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. For intravenous. injection, add sufficient solute to make an approximately isotonic solution.

Water for Injection, USP is chemically designated H2O.

The glass vial is Type I or II borosilicate glass and meets the requirements of the powdered glass test according to the USP standards.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water for distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

The small volume of fluid provided by Sterile Water for Injection, USP when used only as a pharmaceutic aid for diluting or dissolving drugs for parenteral injection, is unlikely to exert a significant effect on fluid balance except possibly in neonates or very small infants.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Sterile Water for Injection, USP must be made approximately isotonic prior to use.

WARNINGS

WARNINGS SECTION

Intravenous administration of Sterile Water for Injection without a solute may result in hemolysis.

PRECAUTIONS

PRECAUTIONS SECTION

Do not use for intravenous injection unless the osmolar concentration of additives results in an approximate isotonic admixture.

Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.

Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.

PREGNANCY SECTION

Pregnancy: Animal reproduction studies have not been conducted with Sterile Water for Injection. It is also not known whether sterile water containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sterile Water for Injection with additives should be given to a pregnant woman only if clearly needed.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness have been established in pediatric patients. However, in neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.

Drug Interactions

DRUG INTERACTIONS SECTION

Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.

Use aseptic technique for single or multiple entry and withdrawal from all containers.

When diluting or dissolving drugs, mix thoroughly and use promptly.

Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.

Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers. Discard unused portion.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

OVERDOSAGE

OVERDOSAGE SECTION

Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS and ADVERSE REACTIONS.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.

This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

HOW SUPPLIED

HOW SUPPLIED SECTION

Sterile Water for Injection, USP is supplied in the following:

Unit of SaleTotal Content
NDC 14789-131-05
Carton of 25 Single-dose Glass
10 mL
NDC 14789-132-05
Carton of 25 Single-dose Glass
20 mL

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Manufactured in the USA by
Nexus Pharmaceuticals, LLC.
Lincolnshire, IL 60069
USA

SWIPI01R01
Revised: 07/2023

Principal Display Panel – 10 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 14789-131-05

Rx Only

Sterile Water for Injection, USP

For Drug Diluent Only

WARNINGS: NOT ISOTONIC, HEMOLYTIC

Use only if clear and seal is intact and undamaged

25 x 10 mL Single-dose Vials

Principal Display Panel – 10 mL Carton Label
Principal Display Panel – 10 mL Carton Label

Principal Display Panel – 10 mL Vial Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 14789-131-07

Rx Only

Sterile Water for
Injection, USP

For Drug Diluent Use Only

WARNINGS: NOT ISOTONIC,
HEMOLYTIC

Do not give intravenously
unless rendered
nearly isotonic

10 mL Single-dose Vial

NEXUS
PHARMACEUTICALS

Principal Display Panel – 10 mL Vial Label
Principal Display Panel – 10 mL Vial Label

Principal Display Panel – 20 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 14789-132-05

Rx Only

Sterile Water for Injection, USP

For Drug Diluent Use Only

WARNINGS: NOT ISOTONIC, HEMOLYTIC

Use only if clear and seal is intact and undamaged

25 x 20 mL Single-dose Vials

Principal Display Panel – 20 mL Carton Label
Principal Display Panel – 20 mL Carton Label

Principal Display Panel – 20 mL Vial Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 14789-132-07

Rx Only

Sterile Water for
Injection, USP

For Drug Diluent Use Only

WARNINGS: NOT ISOTONIC,
HEMOLYTIC

Do not give intravenously
unless rendered nearly isotonic

20 mL Single-dose Vial

NEXUS
PHARMACEUTICALS

Figure
Figure

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
14789-131-05ML - Milliliter14789-13116fa839b-aabe-4afa-bfa9-370c41e0953b12023-10-16
14789-131-07ML - Milliliter14789-131057a5ab5-9e9e-40e4-8849-4e9b99151f1712023-10-16
14789-132-05ML - Milliliter14789-132b0d67ae2-0da2-4fdf-8827-b5941bc20e0412023-10-16
14789-132-07ML - Milliliter14789-132c08cde2a-ec51-49bf-99c7-3ba4a5c5a0df12023-10-16

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
14789-13114789-131-07, 14789-131-05
14789-13214789-132-07, 14789-132-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
Water059QF0KO0RACTIB
Water059QF0KO0RACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
235a0473-d5d5-1206-e063-6394a90ad9db6990b809-8873-4a2c-b7cd-c0387765cb7f2024-09-30Warnings, Adverse reactionsExact identifier
spl set id: 6990b809-8873-4a2c-b7cd-c0387765cb7f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.